A small air bubble may remain at the needle tip, but it will not be injected
Patients who have been on Wegovy or Zepbound through the program would face three options: Pay out of pocket at retail prices (currently $1,000-$1,300 per month) Discontinue the medication , which research suggests leads to significant weight regain Transition to an alternative covered treatment , such as bariatric surgery or other covered medications The STEP 1 extension study showed that patients who discontinued semaglutide regained approximately two-thirds of their lost weight within one year
Exenatide as a weight-loss therapy in extreme pediatric obesity: a randomized, controlled pilot study
Also, growth hormone levels drop as we get older, and there was interest in seeing if tweaking these levels might benefit older adults struggling with loss of bone and muscle mass and increases in body fat
It also slows stomach emptying, which may reduce appetite but can contribute to digestive side effects
[1] [2] Approved in November 2023, Zepbound represents a novel therapeutic approach for significant weight reduction